You are here: Industry Insights > Jubilant

News List

Jubilant Therapeutics appoints Luca Rastelli as Chief Scientific Officer expresspharma
March 10, 2021
Dr Rastelli will lead all aspects of R&D for Jubilant Therapeutics and serve as a scientific liaison for the company to investors, partners and the medical community.
Jubilant, Wistar Institute to Evaluate Novel PAD4 Inhibitors to Reduce Severity of COVID-19 americanpharmaceuticalreview
January 25, 2021
Jubilant Therapeutics has announced a collaboration with The Wistar Institute to evaluate the ability of Peptidyl Arginine Deiminase 4 (PAD4) inhibitors provided by Jubilant Therapeutics to block neutrophil extracellular trap (NET) formation in the ...
DCGI nod for Jubilant’s generic remdesivir under brand name JUBI-R expresspharma
July 21, 2020
The company will distribute the drug in the Indian market through its distribution network and will be available by the first week of August 2020.
Jubilant Therapeutics Appoints President and CEO contractpharma
September 16, 2019
Syed Kazmi's accomplished career includes 25 years in M&A, licensing, strategic collaborations, and R&D in specialty biotech and large pharma.
Jubilant announces 10 per cent price increase for Vitamin B3 expresspharma
July 18, 2019
Jubilant Life Sciences, an integrated global pharmaceutical and life sciences company, has announced a price increase of 10 per cent for its Vitamin B3 (Niacin and Niacinamide) with immediate effect, for non-contract customers and wherever the existing co

Previous page 1 2 Next page